Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Argus Health
AstraZeneca
Healthtrust
US Army
Moodys
Merck
Harvard Business School
Federal Trade Commission

Generated: September 19, 2018

DrugPatentWatch Database Preview

Valeant Luxembourg Company Profile

« Back to Dashboard

What is the competitive landscape for VALEANT LUXEMBOURG, and what generic and branded alternatives to VALEANT LUXEMBOURG drugs are available?

VALEANT LUXEMBOURG has six approved drugs.



Summary for Valeant Luxembourg
US Patents:0
Tradenames:4
Ingredients:5
NDAs:6

Drugs and US Patents for Valeant Luxembourg

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Luxembourg ERTACZO sertaconazole nitrate CREAM;TOPICAL 021385-001 Dec 10, 2003 RX Yes Yes ➤ Sign Up ➤ Sign Up
Valeant Luxembourg GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 062279-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Valeant Luxembourg GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 062279-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Valeant Luxembourg TARGRETIN bexarotene CAPSULE;ORAL 021055-001 Dec 29, 1999 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Valeant Luxembourg

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Luxembourg TARGRETIN bexarotene GEL;TOPICAL 021056-001 Jun 28, 2000 6,043,279 ➤ Sign Up
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 5,214,036 ➤ Sign Up
Valeant Luxembourg TARGRETIN bexarotene GEL;TOPICAL 021056-001 Jun 28, 2000 6,320,074 ➤ Sign Up
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 4,920,143 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for VALEANT LUXEMBOURG drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 75 mg ➤ Subscribe 2011-06-06
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Merck
Express Scripts
Cerilliant
US Army
Cantor Fitzgerald
Boehringer Ingelheim
Deloitte
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.